Tempus AI CFO’s Systematic 10b5‑1 Sales Raise Red Flags Amid Weak Health‑Tech Market

Insider Selling at Tempus AI: What It Means for Investors

A Sudden Drop in Holdings

On March 2, 2026, Chief Financial Officer Rogers James William sold 11,414 shares of Tempus AI’s Class A common stock at $50.69, reducing his position to 127,248 shares. The transaction was executed under a Rule 10b5‑1 trading plan that William adopted on September 11, 2025. While the sale size is modest relative to the company’s $9.53 billion market cap, it follows a pattern of frequent, small‑scale divestitures in the last six months. William’s most recent trade, a purchase of 37,496 shares on February 20, was also part of the same 10b5‑1 plan, suggesting that the CFO is rotating through a predetermined schedule rather than reacting to new information.

Implications for the Stock

The sale coincided with a day of muted trading activity and a 4.5 % weekly decline in the share price, reflecting broader market softness in the health‑care tech space. With a trailing P/E of –37.87, Tempus AI is still far from profitability, and insider outflows—especially from key executives—can amplify concerns about long‑term capital structure and cash flow. Analysts will likely watch for any change in the CFO’s holdings as an early signal of confidence (or lack thereof) in the company’s near‑term outlook.

What Investors Should Watch

• Liquidity and Cash Flow: CFO trading patterns often mirror the company’s cash‑flow health. If William’s 10b5‑1 schedule continues to see large sales, it could indicate the CFO is positioning for a future liquidity event or that the company may need to raise capital.
• Board Dynamics: The CFO’s shares are part of a broader insider activity trend; the CEO and other executives have recently sold or bought sizable blocks. A shift in the board’s composition could affect strategic priorities, especially as Tempus AI transitions from validation to deployment.
• Market Sentiment: The transaction’s sentiment score of +8 and a buzz of 17.35 % show limited social‑media reaction, suggesting that the market did not react strongly. However, the cumulative effect of multiple insider sales may still erode investor confidence.

Rogers James William: A Transactional Profile

William’s trading history since December 2025 shows a balanced mix of purchases and sales. He bought 37,496 shares on February 20, 2026, and sold 10,084 shares on February 19 and again on March 2, totaling 21,498 shares sold over a 10‑day window. Earlier in December, he sold 4,209, 11,982, and 3,775 shares in quick succession, indicating a habit of quarterly portfolio rebalancing. His average transaction price has hovered around $70, suggesting he is not capitalizing on a sharp price rally but rather following a systematic plan. As CFO, his trades are governed by a 10b5‑1 plan, reducing the likelihood of insider tips but increasing the perception that he is hedging personal exposure.

Conclusion

The CFO’s recent sale, while not a headline‑grabbing event on its own, fits into a broader pattern of insider activity that signals cautious positioning. For investors, the key takeaway is that insider schedules can pre‑empt fundamental shifts—such as capital needs or strategic pivots—especially in a company like Tempus AI, whose valuation remains heavily discounted and whose future profitability is uncertain. Keeping an eye on William’s remaining holdings and on the CFO’s trading cadence will provide a useful barometer for the company’s trajectory in the coming quarters.